安徽建工(600502.SH):收到多個項目中標通知書
格隆匯12月22日丨安徽建工(600502.SH)公佈,公司及本公司所屬子公司安徽建工三建集團有限公司、安徽省公路橋樑工程有限公司、安徽建工交通航務集團有限公司、安徽建工王家壩建設投資有限公司收到項目中標通知書。一、聯合體中標阜陽鐵空樞紐現代服務業項目—阜陽智谷產業園項目(B 區)設計施工總承包,中標價11.52億元;二、聯合體中標人民智能產業園項目,中標價9.03億元;三、中標524國道秀洲王江涇至新塍公路工程TJ01標段,中標價6.56億元;四、聯合體中標合肥先進光源國家重大科技基礎設施項目—基礎設施建設施工總承包、合肥先進光源配套工程項目施工總承包(一標段),中標價7.22億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.